|

Ligufalimab Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • University of Texas Southwestern Medical Center1

Indications

  • Liver Disease1
  • Refractory Hepatocellular Carcinoma1
  • Biliary Tract Cancer1
  • Advanced Hepatocellular Carcinoma1
  • Liver Cancer1

Dallas, Texas1 trial

Ligufalimab and Cadonilimab in Advanced Liver Cancers

University of Texas Southwestern Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.